Matthew H Taylor

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Squamous Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Allan Hackshaw, Otto Fajardo, Urania Dafni, André B P van Kuilenburg, Pilar Garrido, Salvatore Siena, Matthew H Taylor, Walter Bordogna, Christos Nikolaidis
Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting. JCO precision oncology 8 (2024)
André B P van Kuilenburg, Albiruni Abdul Razak, Matthew H Taylor, Todd M Bauer, Breelyn A Wilky, Javier Martín-Broto, Alejandro Falcón Gonzalez, Piotr Lukasz Rutkowski, Bartlomiej Szostakowski, Thierry Alcindor, Ramy R Saleh, Sofia Genta, Silvia Stacchiotti, Michiel Adreanus van de Sande, Andrew J Wagner, Nicholas M Bernthal, Lara E Davis, Jacqueline Vuky, Christopher Tait, Bahar Matin, Supraja Narasimhan, Maitreyi G Sharma, Rodrigo Ruiz-Soto, Matthew L Sherman, William D Tap
CSF1R Inhibition in Patients With Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase 1 Study of Vimseltinib. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Allan Hackshaw, Otto Fajardo, Urania Dafni, André B P van Kuilenburg, Pilar Garrido, Salvatore Siena, Matthew H Taylor, Walter Bordogna, Christos Nikolaidis
Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting. JCO precision oncology 8 (2024)
Rona Yaeger, Meredith A McKean, Rizwan Haq, J Thaddeus Beck, Matthew H Taylor, Jonathan Eliezer Cohen, Daniel W Bowles, Shirish M Gadgeel, Catalin Mihalcioiu, Kyriakos P Papadopoulos, Eli L Diamond, Keren B Sturtz, Gang Feng, Stefanie K Drescher, Micaela B Reddy, Bhaswati Sengupta, Arnab Kumar Maity, Suzy A Brown, Anurag Singh, Eric N Brown, Brian R Baer, Jim Wong, Tung-Chung Mou, Wen-I Wu, Dean R Kahn, Sunyana Gadal, Neal X Rosen, John J Gaudino, Patrice A Lee, Dylan P Hartley, S Michael Rothenberg
A next-generation BRAF inhibitor overcomes resistance to BRAF inhibition in patients with BRAF-mutant cancers using pharmacokinetics-informed dose escalation. Cancer discovery (2024)
Allan Hackshaw, Otto Fajardo, Urania Dafni, André B P van Kuilenburg, Pilar Garrido, Salvatore Siena, Matthew H Taylor, Walter Bordogna, Christos Nikolaidis
Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting. JCO precision oncology 8 (2024)
Allan Hackshaw, Otto Fajardo, Urania Dafni, André B P van Kuilenburg, Pilar Garrido, Salvatore Siena, Matthew H Taylor, Walter Bordogna, Christos Nikolaidis
Characteristics and Survival Outcomes of Patients With Metastatic RET Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World Setting. JCO precision oncology 8 (2024)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Vicky Makker, Carol Aghajanian, Allen L Cohn, Margarita Romeo Marin, Raquel Bratos, Marcia S Brose, Mark Messing, Lea Dutta, Corina E Dutcus, Jie Huang, Emmett V Schmidt, Robert Orlowski, Matthew H Taylor
A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 41 (5) (2023)
Matthew H Taylor, Courtney B Betts, Lauren Maloney, Eric Nadler, Alain Patrick Algazi, Michael J Guarino, John J Nemunaitis, Antonio Jimeno, Priti Patel, Veerendra Munugalavadla, Lin Tao, Douglas Adkins, Jerome H Goldschmidt, Ezra E W Cohen, Lisa M Coussens
Safety and Efficacy of Pembrolizumab in Combination With Acalabrutinib in Advanced Head and Neck Squamous Cell Carcinoma: Phase 2 Proof-of-Concept Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)